Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Catalent Inc (NY: CTLT )

61.00 +0.25 (+0.41%)
Official Closing Price Updated: 7:00 PM EST, Nov 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Catalent Inc

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Catalent (CTLT) Stock Pops 10% on Sale to Novo Nordisk
Catalent stock is rising higher on Monday after the company announced a $16.5 billion cash acquisition deal for CTLT shares. 
Via InvestorPlace
Estée Lauder Posts Upbeat Earnings, Joins ON Semiconductor, Tyson Foods And Other Big Stocks Moving Higher On Monday
U.S. stocks traded lower, with the Dow Jones falling over 300 points on Monday. 
Via Benzinga
Topics Stocks
Exposures US Equities
Ozempic Maker Strikes $11B Deal With Catalent As It Rushes To Meet Massive Weight-Loss Drug Demand
This move comes on the heels of the company's recent collaborations to develop new treatment approaches for obesity management and chronic liver diseases. 
Via Benzinga
SHAREHOLDER NEWS: Johnson Fistel Investigates Proposed Sale of Catalent; Is $63.50 a Fair Price?
From Johnson Fistel, LLP
Via Business Wire
Analyst Expectations For Catalent's Future
Via Benzinga
What Happened With Caltalent Stock?
Catalent, Inc. (NYSE: CTLT) shares traded higher on Tuesday. Following losses at the end of October, the stock has rebounded over the past month. 
Via Benzinga
What 9 Analyst Ratings Have To Say About Catalent
Via Benzinga
CTLT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Catalent, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
The biggest pre-market stock movers are starting off the trading week as we check out all of the hottest news for Monday morning! 
Via InvestorPlace
Novo Holdings to Acquire Catalent
From Catalent, Inc.
Via Business Wire
Catalent, Inc. Announces Second Quarter Fiscal Year 2024 Earnings Conference Webcast
From Catalent, Inc.
Via Business Wire
Recap: Catalent Q1 Earnings
Via Benzinga
Preview: Catalent's Earnings
Via Benzinga
Catalent Commits to Reducing Greenhouse Gas Emissions by 2030
From Catalent, Inc.
Via Business Wire
S&P 500 Shatters Records: The Top-Performing Stocks In January 2024
2023 was a historical milestone for S&P 500 as it once again surpassed record highs, largely due to tech giants and artificial intelligence. Top gainers were NVIDIA, Meta Platforms, and AMD. 
Via Benzinga
Topics Artificial Intelligence Stocks
Exposures Artificial Intelligence US Equities
These 9 Stocks Are Running To Start 2024
The S&P 500 is up just 0.2% in 2024. These stocks are off to a strong start. 
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
Catalent, Inc. to Present at the 42nd Annual J.P. Morgan Healthcare Conference
From Catalent, Inc.
Via Business Wire
Catalent Announces Closing of Incremental Term Loans
From Catalent, Inc.
Via Business Wire
Catalent Regains Compliance with NYSE Continued Listing Standards
From Catalent, Inc.
Via Business Wire
Jim Cramer: Buy This Financial Stock, 'I Think They're High Quality'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Vishay Intertechnology, Inc. 
Via Benzinga
Intel To Rally Over 23%? Here Are 10 Top Analyst Forecasts For Thursday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
Catalent's Q1 Performance Beat Expectations: Analyst Says Main Focus On Manufacturing Outlook For Sarepta's Gene Therapy
Catalent Inc's (NYSE: CTLT) Q1 FY24 revenue of $982 million decreased 4% as reported, or 6%, in constant currency, beating the  
Via Benzinga
Target Reports Earnings Beat, Joins AST SpaceMobile, Dada Nexus And Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded higher, with the Dow Jones gaining more than 100 points on Wednesday. Shares of Target Corporation (NYSE: TGT) jumped during Wednesday’s session after the company reported... 
Via Benzinga
Topics Earnings Stocks
Exposures Financial US Equities
US Stocks On Track To Build On Gains As Traders Await A Batch Of Data; Can Market Resist Profit Taking?
U.S. stocks could build on the momentum they picked up on Tuesday following the release of benign inflation data. Traders get to digest another batch of economic data on producer price inflation,... 
Via Benzinga
Topics Economy
Exposures Interest Rates
Catalent, Inc. Reports Preliminary First Quarter Fiscal 2024 Results and Reaffirms Full-Year Fiscal 2024 Guidance
From Catalent, Inc.
Via Business Wire
Sotera Health Appoints Karen Flynn to Board of Directors
From Sotera Health Services, LLC
Via GlobeNewswire
BioMarin Surges As Activist Investor Elliott Reportedly Builds $1 Billion Stake
The company's recently FDA-approved gene therapy is struggling to gain traction. 
Via Investor's Business Daily
What's Going On With Biotech Contract Service Firm Catalent Stock Today?
Catalent Inc (NYSE: CTLT) shares are trading lower due to its significant exposure to Sarepta Therapeutics Inc (NASDAQ: SRPT) on the back of disappointing data from a pivotal gene therapy trial. 
Via Benzinga
Why JetBlue Airways Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 80% to $6.14 after the company announced it received notice of acceptance from the Australian patent office for its patent application for... 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Catalent, Inc. Announces First Quarter Fiscal Year 2024 Earnings Conference Webcast
From Catalent, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.